Compare INTT & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTT | CPIX |
|---|---|---|
| Founded | 1981 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.9M | 34.1M |
| IPO Year | 1997 | 2009 |
| Metric | INTT | CPIX |
|---|---|---|
| Price | $7.59 | $2.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 34.3K | ★ 87.6K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $117,606,000.00 | $41,278,349.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.21 |
| 52 Week Low | $5.24 | $1.85 |
| 52 Week High | $9.77 | $7.25 |
| Indicator | INTT | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 45.67 | 56.08 |
| Support Level | $7.53 | $2.11 |
| Resistance Level | $8.00 | $2.73 |
| Average True Range (ATR) | 0.47 | 0.23 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 23.96 | 72.60 |
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.